Key result
North American ginseng (0.9 g/L) reversed established cardiac hypertrophy, myocardial remodeling, and heart failure in rats and cultured cardiomyocytes.
Why the study?
Does North American ginseng reverse established cardiomyocyte hypertrophy and heart failure in experimental models?
Does North American ginseng reverse established cardiomyocyte hypertrophy and heart failure in experimental models?
In experimental models, North American ginseng reversed established cardiac hypertrophy and heart failure, likely mediated by reversal of calcineurin activation.
No immediate clinical implications for heart failure; leaves open translation of ginseng effects from rodent models to humans.
BACKGROUND: A major challenge in the treatment of heart failure is the ability to reverse already-established myocardial remodeling and ventricular dysfunction, with few available pharmacological agents prescribed for the management of heart failure having demonstrated successful reversal of the remodeling and hypertrophic processes. North American ginseng (Panax quinquefolius) has previously been shown to effectively prevent cardiomyocyte hypertrophy and heart failure. Here, we determined whether North American ginseng can reverse established cardiomyocyte hypertrophy in cultured myocytes as well as hypertrophy and left ventricular dysfunction in experimental heart failure secondary to coronary artery occlusion. METHODS AND RESULTS: Ginseng was administered in drinking water (0.9 g/L) ad libitum to rats after 4 weeks of sustained coronary artery ligation when heart failure was established or to angiotensin II- (100 nmol/L), endothelin-1- (10 nmol/L), or phenylephrine- (10 µmol/L) induced hypertrophic cultured neonatal ventricular cardiomyocytes. Echocardiographic and catheter-based measurements of hemodynamic parameters 4 weeks after starting ginseng treatment (8 weeks postinfarction) revealed nearly complete reversibility of systolic and diastolic abnormalities. Similarly, ginseng administration to hypertrophic cardiomyocytes resulted in a complete reversal to a normal phenotype after 24 hours as determined by cell surface area and expression of molecular markers. The effects of ginseng both in vivo and in cultured cardiomyocytes were associated with reversal of calcineurin activation and reduced nuclear translocation of the transcription factor NFAT3 (nuclear factor of activated T cells 3) in cultured myocytes. Moreover, the beneficial effect of ginseng was associated with normalization in the gene expression of profibrotic markers, including collagen (I and III) and fibronectin. CONCLUSIONS: This study demonstrates a marked ability of ginseng to reverse cardiac hypertrophy, myocardial remodeling, and heart failure, which was associated with and likely mediated by reversal of calcineurin activation. Ginseng may offer a potentially effective approach to reverse the myocardial remodeling and heart failure processes, particularly in combination with other treatment modalities.
No takes yet. Share an insight, caveat, or question.
Moey et al. (2012) studied Heart failure and cardiomyocyte hypertrophy. North American ginseng was evaluated on Reversibility of systolic and diastolic abnormalities and cardiomyocyte phenotype. North American ginseng (0.9 g/L) reversed established cardiac hypertrophy, myocardial remodeling, and heart failure in rats and cultured cardiomyocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: